Somerset Company Profile
What is the competitive landscape for SOMERSET
SOMERSET has one hundred and fifteen approved drugs.
Summary for Somerset
| US Patents: | 0 |
| Tradenames: | 99 |
| Ingredients: | 97 |
| NDAs: | 115 |
| Patent Litigation for Somerset: | See patent lawsuits for Somerset |
Drugs and US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 207639-001 | Jun 23, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 219194-002 | Feb 12, 2025 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Therap | PRUCALOPRIDE SUCCINATE | prucalopride succinate | TABLET;ORAL | 219078-001 | Jun 24, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,150,881 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | RE34579 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-002 | Feb 27, 2006 | RE34579 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

